Prevention of perinatal group B streptococcal infection: Management strategies.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3327343)

Published in Can J Infect Dis on March 01, 1997

Authors

N N Demianczuk1, S A Halperin, D D McMillan

Author Affiliations

1: Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta;

Articles citing this

Reappraisal of guidelines for management of neonates with suspected early-onset sepsis. J Pediatr (2015) 0.85

Prophylactic antibiotics in children. Paediatr Child Health (1999) 0.75

Articles cited by this

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med (1986) 3.96

The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol (1991) 2.78

Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis (1983) 2.14

Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol (1994) 1.90

Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: a critical review of randomized controlled trials. Am J Obstet Gynecol (1994) 1.86

Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis (1990) 1.77

Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA (1993) 1.63

American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics (1992) 1.57

Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol (1993) 1.45

Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis. CMAJ (1993) 1.40

Laboratory and field evaluation of selective media for isolation of group B streptococci. J Clin Microbiol (1979) 1.40

Penicillin in infants weighing two kilograms or less with early-onset Group B streptococcal disease. N Engl J Med (1983) 1.31

A comparison of the yield of positive antenatal group B Streptococcus cultures with direct inoculation in selective growth medium versus primary inoculation in transport medium followed by delayed inoculation in selective growth medium. Am J Obstet Gynecol (1996) 1.21

Strategies for chemoprophylaxis of GBS early-onset infections. Antibiot Chemother (1971) (1985) 1.13

An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection. Obstet Gynecol (1994) 1.07

Group B streptococcal infections. Perinatal impact and prevention methods. Ann N Y Acad Sci (1988) 1.04

Evaluation of colistin and nalidixic acid in Todd-Hewitt broth for selective isolation of group B streptocci. J Clin Microbiol (1979) 1.03

Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization. Am J Obstet Gynecol (1990) 1.01

From the National Institute of Allergy and Infectious Diseases. Summary of the National Institutes of Health workshop on group B streptococcal infection. J Infect Dis (1983) 0.84

Articles by these authors

Variations in practice and outcomes in the Canadian NICU network: 1996-1997. Pediatrics (2000) 3.94

Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis (2001) 3.11

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA (1998) 2.50

Morbidity of pertussis in adolescents and adults. J Infect Dis (2000) 1.95

Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis (2011) 1.84

Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population. Vaccine (1997) 1.63

Consent for clinical research in the neonatal intensive care unit: a retrospective survey and a prospective study. Arch Dis Child Fetal Neonatal Ed (2003) 1.53

Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49

Parental willingness to enter a child in a controlled vaccine trial. Clin Invest Med (1998) 1.24

Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis. J Pediatr (1997) 1.13

Clearance of liquid from lungs of newborn rabbits. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.12

Nutrition and growth analysis of very low birth weight infants. Pediatrics (1990) 1.11

Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J Pediatr (1992) 1.10

Antibody response to bacteriophage hyaluronidase in acute glomerulonephritis after group A streptococcal infection. J Infect Dis (1987) 1.05

Labor decreases the lung water content of newborn rabbits. Am J Obstet Gynecol (1979) 1.05

Oral colonization and immune responses to Streptococcus gordonii expressing a pertussis toxin S1 fragment in mice. FEMS Microbiol Lett (2002) 1.01

Evaluation of the effectiveness of the standardized neonatal resuscitation program. J Perinatol (2001) 1.01

Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii. Infect Immun (1999) 0.98

Attitudinal and resource changes after a neonatal resuscitation training program. Neonatal Netw (1992) 0.98

Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. Am Rev Respir Dis (1983) 0.97

Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis (1985) 0.96

Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun (2005) 0.95

Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis. Clin Exp Immunol (2006) 0.90

Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine? JAMA (2000) 0.89

DNA fingerprinting in investigation of apparent nosocomial acquisition of neonatal herpes simplex. J Pediatr (1980) 0.89

Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordonii. Scand J Immunol (2009) 0.88

Home oxygen therapy. Outcome of infants discharged from NICU on continuous treatment. Clin Pediatr (Phila) (1989) 0.88

Serological correlates of immunity to Bordetella pertussis. Vaccine (1998) 0.88

Administration of Vitamin K to newborns: implications and recommendations. CMAJ (1996) 0.86

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens. Vaccine (2001) 0.86

Oculoglandular syndrome caused by Francisella tularensis. Clin Pediatr (Phila) (1985) 0.84

Decreased pulmonary transvascular fluid filtration in awake newborn lambs after intravenous furosemide. J Clin Invest (1978) 0.84

Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine. Vaccine (2001) 0.84

Comparison of parental and health care professional preferences for the acellular or whole cell pertussis vaccine. Pediatr Infect Dis J (1998) 0.84

Benefits of orotracheal and nasotracheal intubation in neonates requiring ventilatory assistance. Pediatrics (1986) 0.83

Gemella species endocarditis in a child. Can J Infect Dis (2001) 0.82

Bacterial cultures of the lower respiratory tract in normal volunteers with and without experimental rhinovirus infection using a plugged double catheter system. Am Rev Respir Dis (1982) 0.82

Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice. Can J Microbiol (2006) 0.82

Reactogenicity to a live attenuated varicella vaccine in Canadian children. Can J Infect Dis (2000) 0.81

Lung fluid dynamics in awake newborn lambs. J Clin Invest (1977) 0.81

Enzyme-linked immunosorbent assay for identification and measurement of antibodies to group A streptococcal bacteriophage. J Lab Clin Med (1985) 0.80

Problem-based teaching of birth attendants in the Philippines. Health Care Women Int (2001) 0.79

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know. Hum Vaccin Immunother (2015) 0.79

Circulating antidiuretic hormone during labour and in the newborn. Acta Paediatr Scand (1980) 0.78

Pulmonary oxygen toxicity: increased microvascular permeability to protein in unanesthetized lambs. Lymphology (1979) 0.78

Rapid diagnosis of pertussis using the Chinese hamster ovary cell cytotoxicity assay. Eur J Clin Microbiol Infect Dis (1995) 0.77

Thyroxine-binding globulin deficiency in Beckwith syndrome. J Pediatr (1979) 0.77

Educational barriers of nurses caring for sick and at-risk infants in India. Int Nurs Rev (2014) 0.77

Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines. J Pediatr (1999) 0.76

Absence of viremia in primary herpetic gingivostomatitis. Pediatr Infect Dis (1984) 0.76

Heparin is not required for peripheral intravenous locks in neonates. Paediatr Child Health (1999) 0.75

Current practices of adjunctive therapy for pertussis at six Canadian tertiary care pediatric hospitals. Can J Infect Dis (1998) 0.75

Bacterial tracheitis associated with respiratory syncytial virus infection and toxic shock syndrome. CMAJ (1990) 0.75

Changing pattern of clinical illness in children with group A streptococcal bacteremia. Can J Infect Dis (1993) 0.75

Static problems in the medical environment. Med Electron (1981) 0.75

Safety and immunogenicity of a pentavalent combination vaccine (diphtheria, tetanus, acellular pertussis, polio, and haemophilus influenzae type B conjugate) when administered as a fourth dose at 15 to 18 months of age. Hum Vaccin (2005) 0.75

Bolus and continuous infusion of tolazoline in neonates with hypoxemia. Dev Pharmacol Ther (1986) 0.75

Necrotizing enterocolitis: a chronic colonic disease. Can J Surg (1985) 0.75

The role of antioxidants and diet in the prevention or treatment of oxygen-induced lung microvascular injury. Ann N Y Acad Sci (1982) 0.75

A single dose of an effective whole cell pertussis vaccine does not significantly increase protection in children primed with a less effective vaccine. Vaccine (1999) 0.75

Expression of diphtheria toxin in Streptococcus mutans and induction of toxin-neutralizing antisera. Can J Microbiol (2005) 0.75

The histopathology of the upper airway in the neonate following mechanical ventilation. J Pathol (1988) 0.75

Neonatal hyperthermia secondary to a plastic thermal blanket. Crit Care Med (1986) 0.75

Upper urinary tract anomalies in children with adrenogenital syndrome. J Pediatr (1976) 0.75

Movement of water and protein in the fetal and newborn lung. Ann Rech Vet (1977) 0.75

Immunogenicity of a half-dose of adjuvanted 2009 pandemic H1N1 influenza vaccine in adults: a prospective cohort study. Eur J Clin Microbiol Infect Dis (2011) 0.75

Alkali therapy for neonates: where does it stand today? Indian Pediatr (1997) 0.75

Plasma L-arginine concentration, oxygenation index, and systemic blood pressure in premature infants. Crit Care Med (1998) 0.75

Pulmonary transvascular fluid filtration and microvascular permeability to plasma proteins in awake newborn lambs. Chest (1977) 0.75

Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity. Clin Invest Med (1991) 0.75